Interaction of EGFR with the tumour microenvironment: Implications for radiation treatment

详细信息    查看全文

• 作者：Monique M. Nijkamp ; Paul N. Span ; Johan Bussink ; Johannes H.A.M. Ka ; ers
• 关键词：EGFR ; Radiotherapy ; Microenvironment
• 刊名：Radiotherapy and Oncology
• 出版年：2013
• 出版时间：July, 2013
• 年：2013
• 卷：108
• 期：1
• 页码：17-23
• 全文大小：1798 K

文摘

Treatment failure through radioresistance of tumours is associated with activation of the epidermal growth factor receptor (EGFR). Tumour cell proliferation, DNA-repair, hypoxia and metastases-formation are four mechanisms in which EGFR signalling has an important role. In clinical trials, a correlation has been demonstrated between high EGFR expression in tumours and poor outcome after radiotherapy. Inhibition of EGFR signalling pathways improves the effectiveness of radiotherapy of head and neck cancers by overcoming these main mechanisms of radioresistance. The fact that only a minority of the patients respond to EGFR inhibitors reflects the complexity of interactions between EGFR-dependent signalling pathways and the tumour microenvironment. Furthermore, many components of the microenvironment are potential targets for therapeutic interventions. Characterisation of the interaction of EGFR signalling and the tumour microenvironment is therefore necessary to improve the effectiveness of combined modality treatment with radiotherapy and targeted agents. Here, the current status of knowledge is reviewed and directions for future research are discussed.